| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |